The American Academy of Allergy, Asthma and Immunology (AAAAI) has accepted five abstracts examining the latest data from Propeller Health and ResMed. Our findings on asthma care, which include analyzing the direct and indirect cost-savings associated with a digital intervention in uncontrolled asthma, will be presented at the AAAAI Annual Meeting on February 24-27. Read […]

Propeller Health and its research partners presented five abstracts at this year’s European Respiratory Society (ERS) International Congress. Our latest research explored the relationship between respiratory comorbidities and healthcare utilization, the effect of digital health solutions on medication adherence and asthma control, and projected prevalence of COPD by the year 2050. Read brief summaries of […]

Environmental factors, such as air pollution and pollen levels, are influences known to significantly impact overall health. For patients with chronic respiratory conditions, these environmental factors can be triggers that mark the difference between a symptom-free day and an emergency room visit.1,2 However, despite their known health impacts, little research had been done to understand […]

In a recent Propeller Health study, we observed that patients with asthma who used a digital health platform had significant improvements in rescue inhaler use and self-reported activity rates over three months. Data was captured using Propeller’s digital health platform, which includes an inhaler sensor that passively collects medication use data and a mobile app […]

Research continues to show how positive behavior change can play an important role in improving health outcomes, especially among patients with chronic conditions such as asthma and COPD. With three peer-reviewed abstracts accepted for presentation at the Society of Behavioral Medicine (SBM) 2022 Annual Meeting on April 6-9, Propeller Health’s recent findings on patient behavior […]

Announces integrations with multiple leading Electronic Health Record (EHR) systems, introduces a new solution to enable Remote Therapeutic Monitoring (RTM) by healthcare providers, and launches digital platform updates to enable respiratory care at home, in-clinic, and on-the-go. MIAMI, March 7, 2022 – Propeller Health, a leader in digital health for asthma and chronic obstructive pulmonary […]

Findings from a Propeller Health study recently published in The Journal of Allergy and Clinical Immunology demonstrated that patients with asthma who are prescribed once-daily dosing schedules are more likely to adhere to their controller medications than those with twice-daily prescriptions. Medication adherence data was collected from 6,410 patients who used the Propeller digital health […]

More and more patients with chronic conditions like asthma have adopted remote care and digital health tools to self-manage their conditions since the start of the COVID-19 pandemic. Survey results from a recent Propeller Health study to be presented at the 2022 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting found that the […]

This year, the American Academy of Allergy, Asthma and Immunology (AAAAI) has accepted four abstracts authored by Propeller Health and its research partners. Our latest findings on asthma care, including how simplified dose frequency may increase medication adherence and how digital health can support improved pediatric asthma outcomes, will be presented at the AAAAI Annual […]